Tag Archives: Warren Woessner

PLANET BLUE v. NAMCO – Abstract at the “Point of Novelty”

Posted on September 29, 2014 by Warren Woessner

In McRO, Inc. d.b.a. Planet Blue v. Namco Bandai Games America, civ. No. CV 12-10322-GW (FFMx) (C. D. Cal., Sept. 22, 2014), the granted Defendant’s motion for judgment on the pleadings that US Patent numbers 6,307,576 and 6,611, 278, were … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged Alice Corp, Bilski, Blue Planet v. Namco Bandai Games America, intellectual property, Mayo v Prometheus, Patent Law, Warren Woessner | 1 Comment

Genetic Technologies v. LabCorp. – Mayo Redux.

Posted on September 16, 2014 by Warren Woessner

It was Mayo redux with a vengeance in the September 23, 2014 decision in Genetic Technologies Ltd. v. Laboratory Corp. of Amer. Holdings et al., Civil Action No. 12-1736-LPS-CJB (D. Del. 2014). Magistrate Judge Burke released an opinion invalidating claim … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged Genetic Technologies, Judge Burke, Laboratory Corporation, Mayo v Prometheus, Supreme Court, USPTO, Warren Woessner | 2 Comments

FDA Publishes “Purple Book” for Biologicals/Biosimilars

Posted on September 11, 2014 by Warren Woessner

In a major move to get organized for the oncoming wave of biosimilar applications, the FDA has published a “Purple Book” listing licensed (e.g., approved) biologicals and licensed interchangeable biosimilars. Rather than summarize the contents table of the book, linked … Continue reading →

Posted in 2017 Patent Review | Tagged bio, FDA, intellectual property, Purple Book, Warren Woessner | Leave a comment

Indefiniteness After Nautilus – A Very “Delicate Balance”

Posted on September 11, 2014 by Warren Woessner

In Interval Lighting v. AOL, Inc., Appeal no. 2013-1282, -1283, -1284, -1285 (Fed. Cir. Sept. 10, 2014), the appealed indefiniteness finding by the district court was affirmed by the Fed. Cir. panel. This was not surprising, since the disputed term … Continue reading →